A research team led by Prof. Ben Ko Chi-bun, Associate Professor of the PolyU Department of Applied Biology and Chemical ...

Last patient last visit (LPLV) milestone in AFFIRM-1 Phase 3 trial of BNC-210 in social anxiety disorder (SAD) achieved; topline readout ...

Adding fenugreek to your diet could improve your digestive health significantly. Fenugreek seeds are rich in potassium and ...

e-cigarettes continue to be promoted as a smoking cessation by some, while new research highlights dangers for vaping in ...

Tetrandrine, a compound isolated from the root of a traditional Chinese medicine (TCM) Stephania tetrandra, has shown promise ...

Australian skinks possess a remarkable natural immunity to deadly snake venom, stemming from a genetic mutation in a critical ...

Alpha Cognition Inc. (Nasdaq: ACOG), a commercial-stage biopharmaceutical company developing therapies for neurodegenerative diseases, today announced it will present new clinical insights on ...

Antivenom can save lives after mamba bites—but new research shows it may unmask a second paralysis, leaving patients with ...

Prices $35 Million Oversubscribed Public Offering. Alpha Cognition (NASDAQ: ACOG) , a commercial-stage biopharmaceutical company focused on treatments for neurodegenerative diseases, announced the pri ...

Last patient last visit (LPLV) milestone in AFFIRM-1 Phase 3 trial of BNC-210 in social anxiety disorder (SAD) achieved; topline readout anticipated in early Q4 2025 Cash runway extended through fisca ...

SaveHealth reports on advancements in dementia medications, highlighting new treatments that modify disease progression and improve patient quality of life.

Your daily SPF just got backup in the battle against skin cancer. New research suggests a cheap, over-the-counter supplement may help protect against the disease — with benefits showing up in as ...